Developments in neuroimaging: positron emission tomography.

Area of Science:

• Neuroscience
• Medical Imaging
• Neurology

Background:

• Positron emission tomography (PET) is a key in vivo technique for quantitative brain function assessment.
• Parkinson's disease (PD) diagnosis and understanding benefit from PET's ability to detect dopamine deficiency.

Purpose of the Study:

• To highlight the utility of PET in Parkinson's disease research.
• To explore PET's role in identifying biomarkers and understanding disease mechanisms.
• To discuss the future potential of multimodal imaging in PD.

Main Methods:

• Quantitative assessment of brain function using PET.
• Characterization of neurotransmitter systems (dopamine receptors and transporters).
• Investigation of disease mechanisms including protein deposition and neuroinflammation.

Main Results:

• PET aids in identifying dopamine deficiency in Parkinson's disease.
• PET serves as a biomarker for PD and offers insights into motor/non-motor symptoms.
• PET imaging illuminates underlying disease mechanisms like aberrant protein aggregation and neuroinflammation.

Conclusions:

• PET is a valuable tool for Parkinson's disease research and clinical applications.
• Emerging multimodal imaging techniques promise advancements in studying PD.
• PET contributes to a deeper understanding of PD pathophysiology and potential therapeutic targets.